Conmed (CNMD) Free Cash Flow (2010 - 2026)

Conmed's Free Cash Flow history runs 17 years deep, the most recent figure standing at $10.6 million for Q1 2026.

• Quarterly Free Cash Flow fell 71.98% year-over-year to $10.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $123.7 million (down 24.82% YoY) and the FY2025 annual result came in at $150.9 million, down 1.95% from the prior year.
• Free Cash Flow was $10.6 million for Q1 2026 at Conmed, down from $41.2 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $51.5 million in Q4 2023 and bottomed at -$17.3 million in Q4 2022.
• A 5-year average of $25.5 million and a median of $27.1 million in 2024 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2022 — Free Cash Flow sank 156.46% — and 2024, when it soared 434.35%.
• Conmed's Free Cash Flow stood at -$17.3 million in 2022, then soared by 398.37% to $51.5 million in 2023, then dropped by 23.75% to $39.3 million in 2024, then gained by 4.9% to $41.2 million in 2025, then plunged by 74.34% to $10.6 million in 2026.
• Business Quant data shows CNMD's Free Cash Flow at $10.6 million in Q1 2026, $41.2 million in Q4 2025, and $48.5 million in Q3 2025.